Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Irving › NPI 1790721538
Lab

Quest Diagnostics Clinical Laboratories INC

Quest Diagnostics Clinical Laboratories INC was paid $276.76M by Medicaid between Jan 2018 and Dec 2024, across 593 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 18% of everything it billed.

33Billing provider infoQUEST DIAGNOSTICS CLINICAL LABORATORIES INC
IRVING, TX 75063
33aNPI1790721538assigned 06/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$276.76M
24GClaims26,910,771
24DCodes billed593
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#2 of 436
Median peer was paid$17K
This provider vs. median16,045×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$5.0M$10M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,265,871$9.16M
20191,304,451$11.96M
20202,148,820$25.61M
20215,793,820$73.28M
20225,931,742$61.89M
20236,139,569$51.33M
2024incomplete4,326,498$43.53M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 18% 691,967 629,751 $48.58M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4.8% 703,324 656,182 $13.36M
80050 General health panel 4.8% 618,016 598,130 $13.32M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4.7% 699,856 652,931 $13.11M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3.2% 406,244 371,680 $8.72M
80061 Lipid panel 3.0% 1,428,501 1,379,576 $8.33M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2.6% 573,629 545,350 $7.25M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.5% 237,978 195,968 $7.03M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.3% 550,069 527,011 $6.48M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 2.3% 18,820 16,996 $6.44M
80053 Comprehensive metabolic panel 2.1% 1,260,525 1,190,255 $5.76M
86003 1.8% 388,816 97,660 $5.09M
581 more codes
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.8% 303,829 $5.04M
84443 Thyroid stimulating hormone (TSH) 1.8% 768,935 $4.95M
81513 1.8% 81,924 $4.85M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1.7% 126,056 $4.62M
83036 Hemoglobin; glycosylated (A1C) 1.7% 1,103,997 $4.62M
80081 1.6% 106,965 $4.36M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.5% 1,355,334 $4.24M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1.4% 19,197 $3.79M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.3% 99,524 $3.64M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.3% 248,631 $3.57M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.0% 150,142 $2.83M
87086 Culture, bacterial; quantitative colony count, urine <1% 706,592 $2.75M
87799 <1% 99,268 $2.42M
87088 <1% 530,592 $2.04M
86803 <1% 280,095 $1.93M
84439 <1% 444,162 $1.83M
86480 <1% 58,381 $1.80M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 12,207 $1.70M
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 28,855 $1.58M
83013 <1% 50,504 $1.58M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 14,962 $1.51M
80074 <1% 69,040 $1.40M
82728 <1% 217,599 $1.35M
36415 Collection of venous blood by venipuncture <1% 1,067,935 $1.23M
83655 <1% 202,523 $1.16M
82607 <1% 158,050 $1.15M
84403 <1% 84,703 $1.11M
87081 <1% 393,900 $1.11M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 28,630 $1.11M
87512 <1% 45,911 $1.06M
87800 <1% 39,168 $1.03M
86696 <1% 91,575 $1.01M
87070 <1% 253,588 $1.01M
86235 <1% 37,140 $1.01M
87536 <1% 22,021 $897K
87522 Neg quan hep c or qual rna <1% 39,739 $876K
81229 <1% 2,283 $866K
84702 <1% 119,625 $861K
82105 <1% 115,898 $856K
86592 <1% 392,200 $846K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 10,622 $845K
87902 <1% 5,533 $833K
87340 <1% 196,969 $829K
85027 <1% 261,610 $827K
87186 <1% 205,740 $824K
87077 <1% 213,890 $816K
82652 <1% 50,636 $793K
86780 <1% 116,874 $749K
82670 <1% 49,583 $725K
83550 <1% 187,617 $717K
84481 <1% 88,387 $712K
82746 <1% 98,906 $710K
83970 <1% 49,879 $679K
86008 <1% 28,511 $678K
83001 <1% 72,035 $668K
82785 <1% 81,353 $632K
86695 <1% 83,330 $624K
86481 <1% 10,555 $608K
83540 <1% 207,930 $604K
83525 <1% 106,850 $582K
84153 <1% 68,159 $580K
86038 <1% 93,602 $559K
82570 <1% 242,956 $521K
83002 <1% 57,454 $513K
84146 <1% 54,834 $497K
86376 <1% 64,639 $487K
81001 <1% 339,369 $466K
84402 <1% 36,385 $466K
81329 <1% 7,450 $456K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 9,673 $441K
86364 <1% 39,323 $437K
82784 <1% 77,333 $422K
83520 <1% 56,005 $419K
82043 <1% 161,469 $414K
88141 <1% 41,542 $409K
86769 <1% 13,030 $404K
80055 <1% 27,222 $381K
84436 <1% 156,454 $376K
86762 <1% 71,424 $367K
82950 <1% 161,704 $358K
86140 <1% 143,446 $357K
80048 Basic metabolic panel (calcium, ionized) <1% 121,358 $351K
86147 <1% 15,873 $319K
82627 <1% 31,625 $319K
86704 <1% 52,472 $318K
86787 <1% 43,839 $314K
84144 <1% 26,633 $299K
86146 <1% 15,013 $295K
83880 <1% 23,087 $294K
86706 <1% 54,937 $294K
83735 <1% 102,891 $292K
88142 <1% 25,244 $283K
84479 <1% 104,673 $277K
82677 <1% 28,953 $275K
86665 <1% 17,298 $269K
86708 <1% 45,668 $263K
86850 <1% 78,938 $254K
87147 <1% 103,251 $252K
87660 <1% 35,152 $250K
86160 <1% 27,869 $248K
86800 <1% 31,849 $246K
80076 <1% 64,316 $245K
84480 <1% 45,438 $244K
83498 <1% 20,274 $238K
82951 <1% 38,589 $235K
86317 <1% 32,985 $231K
87209 <1% 27,275 $227K
83516 <1% 44,890 $224K
84270 <1% 20,454 $224K
83020 <1% 39,001 $209K
82248 <1% 93,217 $208K
85652 <1% 158,924 $208K
87481 <1% 7,678 $193K
86360 <1% 9,816 $192K
84305 <1% 17,172 $182K
86336 <1% 29,108 $181K
86258 <1% 12,334 $178K
86200 <1% 27,359 $177K
87480 <1% 35,381 $176K
87510 <1% 35,326 $176K
80349 <1% 23,258 $171K
86039 <1% 30,045 $166K
84550 <1% 85,475 $161K
87563 <1% 8,842 $160K
85610 <1% 90,385 $158K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 7,339 $153K
86431 <1% 52,337 $151K
84460 <1% 106,335 $151K
86225 <1% 22,162 $144K
84445 <1% 5,998 $141K
82274 <1% 17,570 $141K
87506 <1% 1,424 $138K
85730 <1% 56,394 $138K
80361 <1% 21,651 $137K
86361 <1% 9,733 $132K
87901 <1% 980 $128K
80164 <1% 22,981 $127K
83993 <1% 14,181 $127K
84156 <1% 90,606 $126K
85018 <1% 119,689 $126K
82533 <1% 15,769 $125K
86255 <1% 23,582 $125K
82977 <1% 39,028 $123K
84425 <1% 11,253 $123K
82550 <1% 42,337 $123K
87177 <1% 26,890 $123K
80069 <1% 43,232 $123K
87338 <1% 17,555 $121K
83690 <1% 35,313 $120K
80348 <1% 19,502 $119K
82024 <1% 5,837 $117K
84681 <1% 12,460 $114K
80358 <1% 20,677 $114K
82247 <1% 70,087 $112K
84450 <1% 76,967 $110K
84100 <1% 61,832 $110K
86664 <1% 14,272 $108K
87529 <1% 4,708 $108K
87427 <1% 18,753 $105K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 1,376 $104K
82157 <1% 7,402 $104K
82542 <1% 10,057 $100K
83021 <1% 10,823 $99K
87045 <1% 22,510 $99K
88262 <1% 2,819 $98K
85246 <1% 9,508 $94K
81511 <1% 2,713 $93K
84134 <1% 15,935 $93K
87449 <1% 18,047 $92K
85245 <1% 8,845 $87K
87625 <1% 4,956 $86K
86341 <1% 9,967 $84K
82947 <1% 56,297 $84K
86901 <1% 74,573 $83K
86900 <1% 74,609 $83K
88230 <1% 2,894 $82K
84703 <1% 20,980 $81K
87329 <1% 14,596 $81K
80346 <1% 13,653 $81K
83014 <1% 20,416 $79K
82150 <1% 25,272 $79K
80177 <1% 14,080 $77K
85240 <1% 9,665 $75K
81003 <1% 69,831 $75K
83615 <1% 27,158 $75K
86334 <1% 10,075 $75K
80354 <1% 16,451 $74K
87581 <1% 3,060 $74K
99001 <1% 22,834 $74K
82672 <1% 6,374 $73K
80197 <1% 22,964 $72K
86812 <1% 6,109 $72K
86381 <1% 4,823 $72K
85014 <1% 66,013 $71K
86300 <1% 6,712 $70K
87075 <1% 15,540 $70K
84154 <1% 8,899 $70K
86141 <1% 9,999 $69K
85060 <1% 6,745 $68K
81243 <1% 5,650 $68K
80324 <1% 12,152 $67K
86359 <1% 4,632 $67K
87900 <1% 976 $65K
82378 <1% 7,998 $65K
83521 <1% 3,277 $62K
80365 <1% 11,379 $61K
82952 <1% 33,198 $61K
82657 <1% 7,997 $58K
80321 <1% 8,792 $57K
86735 <1% 8,432 $57K
80323 <1% 6,734 $57K
84165 <1% 15,051 $55K
86765 <1% 8,455 $55K
87517 <1% 3,608 $55K
82140 <1% 8,732 $54K
86304 <1% 6,114 $54K
85660 <1% 20,287 $53K
82088 <1% 2,775 $53K
85045 <1% 27,605 $53K
83992 <1% 6,035 $52K
83721 <1% 18,552 $51K
82653 <1% 2,618 $51K
87255 <1% 2,863 $50K
88342 <1% 1,533 $50K
84207 <1% 3,865 $50K
82565 <1% 23,984 $49K
82172 <1% 7,754 $48K
80299 <1% 3,809 $48K
82465 <1% 76,042 $47K
83090 <1% 7,902 $47K
86593 <1% 21,577 $47K
82610 <1% 6,614 $47K
81443 <1% 1,041 $47K
86870 <1% 5,067 $47K
84244 <1% 4,289 $46K
86645 <1% 5,594 $45K
85247 <1% 4,906 $45K
87535 <1% 3,055 $45K
82390 <1% 8,401 $44K
86644 <1% 6,207 $43K
86015 <1% 5,497 $42K
87205 <1% 20,069 $42K
80362 <1% 12,255 $41K
80373 <1% 11,852 $40K
85613 <1% 8,240 $40K
81241 <1% 2,646 $39K
88304 <1% 1,749 $39K
82330 <1% 6,887 $39K
88185 <1% 383 $38K
86021 <1% 5,741 $38K
84590 <1% 6,349 $37K
88341 <1% 694 $37K
80368 <1% 10,803 $36K
84630 <1% 6,463 $36K
81596 <1% 4,165 $36K
86162 <1% 4,387 $36K
84478 <1% 61,793 $36K
83704 <1% 3,366 $35K
82040 <1% 39,430 $35K
87497 <1% 3,294 $35K
80356 <1% 6,707 $35K
87046 <1% 7,785 $35K
87493 <1% 2,135 $34K
81025 <1% 8,929 $33K
82310 <1% 18,385 $33K
83921 <1% 4,176 $33K
83718 <1% 58,849 $32K
86036 <1% 3,244 $32K
80353 <1% 7,414 $32K
87324 <1% 5,847 $31K
83695 <1% 6,416 $31K
86355 <1% 1,681 $31K
87662 <1% 742 $31K
85041 <1% 23,185 $31K
84182 <1% 951 $30K
84446 <1% 4,381 $30K
86231 <1% 2,696 $30K
81206 <1% 615 $30K
84432 <1% 4,167 $30K
80178 <1% 9,620 $29K
85379 <1% 5,905 $29K
87101 <1% 7,999 $28K
80345 <1% 5,952 $27K
80374 <1% 7,366 $27K
80338 <1% 5,199 $27K
80320 <1% 5,650 $27K
80372 <1% 9,643 $26K
80183 <1% 4,601 $26K
82626 <1% 2,227 $26K
82103 <1% 4,413 $26K
86747 <1% 2,324 $25K
84466 <1% 4,528 $25K
84132 <1% 10,965 $25K
86777 <1% 3,499 $25K
80370 <1% 5,004 $25K
83519 <1% 4,233 $24K
80355 <1% 9,218 $24K
80337 <1% 5,009 $23K
80363 <1% 2,585 $22K
86705 <1% 5,667 $22K
80175 <1% 4,328 $22K
87150 <1% 1,427 $22K
86709 <1% 5,563 $22K
80360 <1% 5,429 $22K
82397 <1% 2,796 $21K
84075 <1% 31,952 $21K
85306 <1% 2,539 $21K
86778 <1% 2,991 $21K
80326 <1% 5,012 $21K
80156 <1% 4,645 $21K
99199 Unlisted special service, procedure or report <1% 15,929 $21K
86357 <1% 1,112 $21K
82085 <1% 4,328 $21K
80332 <1% 2,390 $21K
84155 <1% 37,911 $20K
83883 <1% 5,070 $20K
86337 <1% 2,040 $20K
82525 <1% 3,384 $20K
81015 <1% 14,365 $20K
82107 <1% 839 $20K
80359 <1% 4,692 $19K
81512 <1% 880 $19K
82787 <1% 2,990 $19K
81240 <1% 1,667 $19K
86060 <1% 4,859 $19K
80377 <1% 4,907 $18K
87906 <1% 317 $18K
84484 <1% 3,563 $18K
86611 <1% 4,442 $18K
84166 <1% 3,412 $18K
84520 <1% 12,131 $18K
81291 <1% 2,107 $17K
82104 <1% 2,934 $17K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 523 $17K
80159 <1% 1,886 $16K
80342 <1% 2,294 $16K
85303 <1% 2,367 $16K
80185 <1% 3,833 $16K
86682 <1% 2,083 $15K
82239 <1% 2,168 $15K
80369 <1% 6,830 $15K
86301 <1% 1,710 $15K
86308 <1% 5,672 $14K
88312 <1% 297 $14K
86632 <1% 2,346 $14K
86774 <1% 2,294 $14K
87107 <1% 2,815 $13K
82985 <1% 2,050 $13K
86618 <1% 1,612 $13K
80051 <1% 4,741 $13K
82747 <1% 2,425 $13K
86648 <1% 2,051 $13K
83698 <1% 1,662 $13K
80364 <1% 2,595 $13K
82139 <1% 1,802 $12K
87102 <1% 3,475 $12K
84295 <1% 6,851 $12K
80366 <1% 3,490 $12K
80235 <1% 1,460 $12K
84143 <1% 1,049 $12K
80329 <1% 2,486 $12K
87106 <1% 2,579 $12K
82530 <1% 1,417 $11K
87650 <1% 655 $11K
85007 <1% 6,727 $11K
85300 <1% 2,071 $11K
82668 <1% 1,828 $11K
86702 <1% 2,303 $11K
80165 <1% 1,999 $11K
80333 <1% 2,583 $11K
80357 <1% 2,840 $11K
84482 <1% 1,430 $11K
80367 <1% 2,670 $11K
87040 <1% 2,435 $11K
85384 <1% 3,103 $10K
86738 <1% 1,037 $10K
82164 <1% 1,689 $10K
81257 <1% 569 $10K
87350 <1% 1,596 $10K
86880 <1% 3,698 $10K
81270 <1% 364 $10K
81401 <1% 361 $9K
88307 <1% 38 $9K
82379 <1% 1,379 $9K
81376 <1% 184 $9K
87076 <1% 2,135 $9K
86335 <1% 1,514 $9K
82166 <1% 646 $9K
82435 <1% 4,975 $9K
83010 <1% 1,945 $9K
83835 <1% 1,141 $9K
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) <1% 2,099 $9K
81207 <1% 182 $8K
84597 <1% 1,187 $8K
80340 <1% 2,588 $8K
80344 <1% 2,589 $8K
80201 <1% 1,505 $8K
86001 <1% 639 $8K
87631 <1% 101 $8K
86256 <1% 1,444 $8K
84140 <1% 752 $8K
87206 <1% 3,522 $8K
82017 <1% 1,018 $7K
87328 <1% 1,179 $7K
86701 <1% 2,303 $7K
86886 <1% 2,758 $7K
82374 <1% 3,655 $7K
82955 <1% 1,520 $7K
80339 <1% 2,133 $7K
86148 <1% 1,355 $7K
87220 <1% 3,540 $7K
88112 <1% 234 $7K
83605 <1% 1,127 $6K
82232 <1% 1,410 $6K
81374 <1% 421 $6K
83918 <1% 667 $6K
89055 <1% 3,035 $6K
80184 <1% 1,562 $6K
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 2,093 $6K
80335 <1% 5,023 $6K
85048 <1% 4,866 $6K
82705 <1% 2,053 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 687 $6K
88184 <1% 204 $5K
80203 <1% 1,253 $5K
80195 <1% 1,059 $5K
80158 <1% 962 $5K
81050 <1% 3,490 $5K
84080 <1% 792 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 172 $5K
82575 <1% 1,280 $5K
82180 <1% 1,003 $5K
83930 <1% 1,771 $5K
81382 <1% 78 $5K
80330 <1% 2,587 $5K
86684 <1% 843 $5K
84376 <1% 1,768 $5K
85598 <1% 646 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 317 $5K
86671 <1% 780 $4K
83003 <1% 622 $4K
87185 <1% 1,744 $4K
83935 <1% 1,670 $4K
85597 <1% 486 $4K
87641 <1% 115 $4K
85004 <1% 1,508 $4K
81400 <1% 425 $3K
88189 <1% 87 $3K
87425 <1% 705 $3K
83825 <1% 463 $3K
86753 <1% 523 $3K
82681 <1% 465 $3K
82175 <1% 373 $3K
84300 <1% 1,483 $3K
86631 <1% 457 $3K
84255 <1% 380 $3K
86905 <1% 1,584 $3K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 2,909 $3K
83874 <1% 349 $2K
82553 <1% 419 $2K
82608 <1% 293 $2K
85049 <1% 1,330 $2K
87254 <1% 231 $2K
81361 <1% 123 $2K
84588 <1% 93 $2K
86707 <1% 621 $2K
84252 <1% 247 $2K
86356 <1% 157 $2K
86316 <1% 280 $2K
83625 <1% 414 $2K
85651 <1% 787 $2K
87634 <1% 143 $2K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 803 $1K
87272 <1% 295 $1K
86757 <1% 83 $1K
84586 <1% 45 $1K
82010 <1% 395 $1K
85305 <1% 285 $1K
81205 <1% 123 $1K
82384 <1% 109 $1K
84133 <1% 604 $1K
84210 <1% 192 $1K
82679 <1% 88 $1K
82731 <1% 50 $1K
86617 <1% 93 $1K
86343 <1% 331 $995.86
86161 <1% 312 $961.35
85250 <1% 107 $945.01
87521 Neg quan hep c or qual rna <1% 40 $921.96
82552 <1% 167 $867.30
82340 <1% 348 $840.76
81279 <1% 27 $815.94
85302 <1% 144 $791.65
81381 <1% 162 $765.84
85520 <1% 111 $750.97
81250 <1% 111 $724.96
81255 <1% 124 $665.38
87341 <1% 139 $624.42
86663 <1% 86 $617.88
81200 <1% 111 $611.00
81290 <1% 119 $592.32
87280 <1% 97 $588.73
81330 <1% 123 $582.70
82507 <1% 50 $582.49
81242 <1% 119 $571.36
81350 <1% 24 $538.20
86606 <1% 53 $521.04
81209 <1% 123 $487.24
81260 <1% 123 $487.24
36416 <1% 6,502 $482.98
87184 <1% 145 $463.46
85670 <1% 182 $458.96
84238 <1% 957 $455.87
87276 <1% 786 $450.53
85301 <1% 109 $435.99
88271 <1% 33 $431.82
81339 <1% 16 $427.01
82523 <1% 63 $408.87
87275 <1% 786 $407.67
81479 Unlisted molecular pathology procedure <1% 845 $386.45
80202 <1% 70 $383.05
80210 <1% 38 $380.56
86794 <1% 30 $377.83
86790 <1% 80 $371.59
83945 <1% 64 $355.79
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 1,883 $353.83
87140 <1% 132 $344.46
86041 <1% 44 $332.74
86403 <1% 75 $332.54
80375 <1% 28 $317.22
84260 <1% 29 $283.72
80169 <1% 60 $282.36
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 6,825 $279.80
87420 <1% 41 $269.13
82656 <1% 24 $264.74
80162 <1% 176 $264.39
84105 <1% 110 $240.14
84560 <1% 115 $216.37
84163 <1% 27 $212.08
80371 <1% 25 $209.89
86635 <1% 39 $206.61
83986 <1% 173 $188.63
82634 <1% 12 $178.48
84442 <1% 27 $177.67
86615 <1% 48 $172.14
87807 <1% 40 $162.87
86703 <1% 12 $160.98
87172 <1% 81 $156.97
84591 <1% 26 $144.04
82436 <1% 67 $140.93
80325 <1% 14 $140.26
86788 <1% 15 $131.65
81251 <1% 129 $126.40
84145 <1% 13 $122.32
86789 <1% 15 $112.36
88289 <1% 12 $106.25
80168 <1% 13 $85.35
87015 <1% 40 $77.96
82642 <1% 12 $77.12
88300 <1% 14 $75.84
83497 <1% 13 $73.27
87207 <1% 25 $52.00
80157 <1% 30 $41.80
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 1,415 $41.39
80161 <1% 13 $34.82
86043 <1% 12 $33.03
83789 <1% 207 $24.04
82540 <1% 13 $8.22
89051 <1% 13 $6.23
3048F 0% 24,666 $0.00
3044F 0% 25,812 $0.00
3052F 0% 719 $0.00
3049F 0% 8,440 $0.00
80415 0% 12 $0.00
G0475 Hiv antigen/antibody, combination assay, screening 0% 64 $0.00
0346U 0% 12 $0.00
3046F 0% 1,125 $0.00
3050F 0% 3,711 $0.00
3051F 0% 1,075 $0.00
83876 0% 67 $0.00
0001M 0% 28 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTIMMERMAN, LEAH (SR. VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Same official

Other billing entities under TIMMERMAN, LEAH

Full network →
ProviderLocationPaid
Unilab CorporationWest Hills, CA$668.50M
Quest Diagnostics IncorporatedClifton, NJ$637.74M
Quest Diagnostics LLC IlWood Dale, IL$429.84M
Labone LLCLenexa, KS$212.28M
Quest Diagnostics Clinical Laboratories INCTucker, GA$211.13M
Quest Diagnostics Clinical Laboratories INCMiramar, FL$197.58M
Labone of Ohio INCCincinnati, OH$167.17M
Unilab CorporationSacramento, CA$141.24M
Quest Diagnostics Incorporated MDBaltimore, MD$121.81M
Quest Diagnostics IncorporatedLas Vegas, NV$59.32M
Quest Diagnostics LLC IlSchaumburg, IL$50.71M
Quest Diagnostics Clinical Laboratories INCTampa, FL$49.99M
Quest Diagnostics Nichols Institute, INC.Chantilly, VA$46.91M
Quest Diagnostics Nichols InstituteSan Juan Capistrano, CA$39.93M
Quest Diagnostics Clinical Laboratories INCNorristown, PA$22.72M
Specialty Laboratories INCWest Hills, CA$16.76M
Quest Diagnostics Clinical Laboratories INCDenver, CO$14.27M
Quest Diagnostics Clinical Laboratories INCHouston, TX$8.76M
Med Fusion, LLCLewisville, TX$4.17M
Quest Diagnostics Clinical Laboratories INCMaryland Heights, MO$2.98M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.